The trajectory of companies tied to Sildenafil's legacy presents a complex investment landscape. While the initial success generated substantial profits , generic copies have significantly eroded revenue. https://sociallawy.com/story12225205/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-risky-opportunity